A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity

BACKGROUND: Tacrolimus is a widely used calcineurin inhibitor in kidney transplantation. It is available as twice-daily Prograf® (Tac-BID) and once-daily Advagraf® (Tac-OD). Although therapeutically equivalent, some patients require dose adjustments to achieve similar trough concentrations [C(0)] af...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Glick, Lauren, Shamy, Fernanda, Nash, Michelle, Sokwala, Ahmed, Malavade, Tushar, Prasad, GV Ramesh, Zaltzman, Jeffrey S
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2014
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3995788/
https://ncbi.nlm.nih.gov/pubmed/24606676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-1440-3-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares